These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9354032)

  • 21. Lipopolysaccharide enhances monocyte adherence to matrix-bound fibronectin.
    Roth P; Polin RA
    Clin Immunol Immunopathol; 1990 Dec; 57(3):363-73. PubMed ID: 2147132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
    Haverstick DM; Cowan JF; Yamada KM; Santoro SA
    Blood; 1985 Oct; 66(4):946-52. PubMed ID: 3876125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional role of arg-gly-asp (RGD)-binding sites on beta1 integrin in embryo implantation using mouse blastocysts and human decidua.
    Shiokawa S; Yoshimura Y; Sawa H; Nagamatsu S; Hanashi H; Sakai K; Ando M; Nakamura Y
    Biol Reprod; 1999 Jun; 60(6):1468-74. PubMed ID: 10330107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin).
    Straus AH; Carter WG; Wayner EA; Hakomori S
    Exp Cell Res; 1989 Jul; 183(1):126-39. PubMed ID: 2544438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesive interaction of hemopoietic progenitor cell membrane with the RGD domain of fibronectin.
    Minguell JJ; Hardy CL; Tavassoli M
    Biochim Biophys Acta; 1993 Sep; 1151(2):120-6. PubMed ID: 8373786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular interactions between fibronectin and integrins during mouse blastocyst outgrowth.
    Yelian FD; Yang Y; Hirata JD; Schultz JF; Armant DR
    Mol Reprod Dev; 1995 Aug; 41(4):435-48. PubMed ID: 7576611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells.
    Sakata N; Sasatomi Y; Meng J; Ando S; Uesugi N; Takebayashi S; Nagai R; Horiuchi S
    Connect Tissue Res; 2000; 41(3):213-28. PubMed ID: 11264870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence.
    Greenspoon N; Hershkoviz R; Alon R; Varon D; Shenkman B; Marx G; Federman S; Kapustina G; Lider O
    Biochemistry; 1993 Feb; 32(4):1001-8. PubMed ID: 8093840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of an RGD ALB conjugate. In vitro analysis of cellular responses.
    Takatsuka M; Kishida A; Matsuda T
    ASAIO J; 1992; 38(3):M275-8. PubMed ID: 1457864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin.
    Mohri H; Tanabe J; Katoh K; Okubo T
    Peptides; 1995; 16(2):263-8. PubMed ID: 7784256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg).
    Vassilev TL; Kazatchkine MD; Duong Van Huyen JP; Mekrache M; Bonnin E; Mani JC; Lecroubier C; Korinth D; Baruch D; Schriever F; Kaveri SV
    Blood; 1999 Jun; 93(11):3624-31. PubMed ID: 10339467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations.
    Elices MJ; Urry LA; Hemler ME
    J Cell Biol; 1991 Jan; 112(1):169-81. PubMed ID: 1986004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
    Mooradian DL; McCarthy JB; Cameron JD; Skubitz AP; Furcht LT
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3034-40. PubMed ID: 1399408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.
    Pytela R; Pierschbacher MD; Ginsberg MH; Plow EF; Ruoslahti E
    Science; 1986 Mar; 231(4745):1559-62. PubMed ID: 2420006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function.
    Aota S; Nomizu M; Yamada KM
    J Biol Chem; 1994 Oct; 269(40):24756-61. PubMed ID: 7929152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
    Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidyl antithrombogenic agents for extracorporeal blood circulation.
    Ito S; Matsuda T; Takemoto Y; Yamamoto K; Kishimoto T; Maekawa M
    Int J Artif Organs; 1992 Dec; 15(12):737-45. PubMed ID: 1493949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4).
    Anwar AR; Walsh GM; Cromwell O; Kay AB; Wardlaw AJ
    Immunology; 1994 Jun; 82(2):222-8. PubMed ID: 7927493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.